# US 2021/0171507 A1 · Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171507 A1
- Document ID: US20210171507A1
- Status: Published application
- Kind: A1
- Application number: 16/937,437
- Filed: 2020-07-23
- Published: 2021-06-10
- Earliest claimed: 2001-07-16
- Assignees: Genzyme Corporation
- Applicants: Genzyme Corporation
- Inventors: Bradford H. HIRTH; Craig SIEGEL
- Web page: https://patentgrep.com/patent/US20210171507A1

## CPC

- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- A61K 31/4025: not condensed and containing further heterocyclic rings, e.g. cromakalim
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 7/06: Antianaemics
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 27/02: Ophthalmic agents
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 295/185: from aliphatic carboxylic acids
- C07D 319/18: Ethylenedioxybenzenes, not substituted on the hetero ring
- C07D 498/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed is a novel enantiomeric synthesis ceramide-like inhibitors of UDP-glucose:N-acylsphingosine glucosyltransferase. Also disclosed are novel intermediates formed during the synthesis.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A method of preparing a compound of formula (2)
said method comprising reacting a compound of formula (1)
with pyrrolidine, followed by hydrolysis.

### Claim 25 (depends on 24)

The method of claim 24, wherein the hydrolysis is carried out using methanol as solvent.

### Claim 26 (depends on 24)

The method of claim 24, wherein the compound of formula (1) is prepared by reacting (5S)-5-phenylmorpholin-2-one with 1,4-benzodioxan-6-carboxaldehyde.

### Claim 27 (depends on 26)

The method of claim 26, wherein (5S)-5-phenylmorpholin-2-one is prepared by reacting a compound of formula (i)
with a compound of formula (ii)

### Claim 28 (depends on 24)

The method of claim 24, further comprising reducing the compound of formula (2) to form a compound of formula (3)

### Claim 29 (depends on 28)

The method of claim 28, wherein the reduction is carried out using lithium aluminum hydride.

### Claim 30

A method of preparing a compound of formula (3)
said method comprising reducing a compound of formula (2)

### Claim 31 (depends on 30)

The method of claim 30, wherein the reduction is carried out using lithium aluminum hydride.

### Claim 32 (depends on 30)

The method of claim 30, wherein the compound of formula (2) is prepared by reacting a compound of formula (1)
with pyrrolidine, followed by hydrolysis.

### Claim 33 (depends on 32)

The method of claim 32, wherein the hydrolysis is carried out using methanol as solvent.

### Claim 34 (depends on 32)

The method of claim 32, wherein the compound of formula (1) is prepared by reacting (5S)-5-phenylmorpholin-2-one with 1,4-benzodioxan-6-carboxaldehyde.

### Claim 35 (depends on 34)

The method of claim 34, wherein (5S)-5-phenylmorpholin-2-one is prepared by reacting a compound of formula (i)
with a compound of formula (ii)
